American Healthcare REIT (AHR) Form 144: Proposed Sale of 3,850 Shares

Rhea-AI Filing Summary

Form 144 filed for American Healthcare REIT, Inc. (AHR) reports a proposed sale of 3,850 shares of common stock with an aggregate market value of $161,271.00. The filing lists 168,575,204 shares outstanding and an approximate sale date of 09/03/2025 on the NYSE through Merrill (8890 Lyra Dr, Columbus, OH). The securities to be sold were acquired as restricted stock that vested on 08/26/2024 (1,242 shares) and 09/03/2024 (2,608 shares), both from American Healthcare REIT, Inc. The filer indicates no securities sold in the past three months and includes the required representation about absence of undisclosed material adverse information.

Insights

Securities Analyst

TL;DR Insider plans a small sale of vested restricted shares totaling 3,850 common shares valued at $161,271.

The filing documents a routine Form 144 notice for the proposed sale of shares received through restricted stock vesting. The source of the shares is the issuer via compensation vesting events on 08/26/2024 and 09/03/2024. The filing reports no other sales in the prior three months and identifies the broker and intended exchange. From a market-materiality perspective, the disclosed quantity and value are modest relative to the total shares outstanding listed in the filing.

Corporate Governance Expert

TL;DR This is a compliance-driven disclosure of insider sales following restricted stock vesting, without additional governance flags in the form.

The Form 144 meets the regulatory requirement to notify the market of proposed insider sales stemming from compensation vesting. It includes acquisition dates, vesting as the nature of acquisition, and the broker/exchange details. The filer also makes the standard certification about lack of undisclosed material adverse information. There is no indication in this filing of extraordinary governance events or accelerated dispositions beyond the disclosed proposed sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill 8890 Lyra Dr 5th Flr Columbus OH 43240	3850	161271.00	168575204	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	08/26/2024	Restricted stock vest	American Healthcare REIT, Inc			1242	08/26/2024	na
Common	09/03/2024	Restricted stock vest	American Healthcare REIT, Inc			2608	09/03/2024	na

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for American Healthcare REIT (AHR) disclose?

The Form 144 discloses a proposed sale of 3,850 common shares valued at $161,271.00, with an approximate sale date of 09/03/2025, via Merrill on the NYSE.

How were the shares in the AHR Form 144 acquired?

The shares were acquired as restricted stock vesting from American Healthcare REIT, Inc., on 08/26/2024 (1,242 shares) and 09/03/2024 (2,608 shares).

Does the Form 144 report any securities sold in the past three months?

No. The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are listed for the proposed sale in the AHR Form 144?

The broker listed is Merrill (8890 Lyra Dr, 5th Flr, Columbus, OH 43240) and the intended exchange is the NYSE.

What representation does the filer make about material information?

The filer represents by signing the notice that they do not know any material adverse information regarding the issuer that has not been publicly disclosed.